- |||||||||| Aurora-GT (endothelial nitric oxide-synthase-enhanced endothelial progenitor cells) / Northern Therap, MaxCyte, United Therapeutics Corp
Enrollment closed, Enrollment change, Trial completion date, Trial primary completion date: SAPPHIRE: Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension: Intervention With Repeat Dosing of eNOS-enhanced EPCs (clinicaltrials.gov) - Jan 11, 2023 P2/3, N=12, Active, not recruiting, Trial completion date: Dec 2023 --> Dec 2033 Recruiting --> Active, not recruiting | N=45 --> 12 | Trial completion date: Dec 2025 --> Dec 2023 | Trial primary completion date: Dec 2025 --> Dec 2023
- |||||||||| Aurora-GT (endothelial nitric oxide-synthase-enhanced endothelial progenitor cells) / Northern Therap, MaxCyte, United Therapeutics Corp
Trial completion date: ENACT-AMI: The Enhanced Angiogenic Cell Therapy - Acute Myocardial Infarction Trial (clinicaltrials.gov) - Dec 2, 2020 P2b, N=47, Active, not recruiting, Trial completion date: Apr 2021 --> Dec 2023 | Trial primary completion date: Oct 2020 --> Dec 2023 Trial completion date: Mar 2030 --> Sep 2030
- |||||||||| Aurora-GT (endothelial nitric oxide-synthase-enhanced endothelial progenitor cells) / Northern Therap, MaxCyte, United Therapeutics Corp
Enrollment closed, Enrollment change, Trial completion date, Trial primary completion date: ENACT-AMI: The Enhanced Angiogenic Cell Therapy - Acute Myocardial Infarction Trial (clinicaltrials.gov) - Nov 26, 2019 P2b, N=47, Active, not recruiting, Trial completion date: Mar 2030 --> Sep 2030 Recruiting --> Active, not recruiting | N=100 --> 47 | Trial completion date: Dec 2019 --> Mar 2030 | Trial primary completion date: Dec 2018 --> Mar 2020
- |||||||||| Aurora-GT (endothelial nitric oxide-synthase-enhanced endothelial progenitor cells) / Northern Therap, MaxCyte, United Therapeutics Corp
Trial completion date, Trial primary completion date: ENACT-AMI: The Enhanced Angiogenic Cell Therapy - Acute Myocardial Infarction Trial (clinicaltrials.gov) - Feb 7, 2018 P2b, N=100, Recruiting, Recruiting --> Active, not recruiting | N=100 --> 47 | Trial completion date: Dec 2019 --> Mar 2030 | Trial primary completion date: Dec 2018 --> Mar 2020 Trial primary completion date: Dec 2016 --> Dec 2018 | Trial completion date: Dec 2016 --> Dec 2019
- |||||||||| Aurora-GT (endothelial nitric oxide-synthase-enhanced endothelial progenitor cells) / Northern Therap, MaxCyte, United Therapeutics Corp
Trial initiation date: ENACT-AMI: The Enhanced Angiogenic Cell Therapy - Acute Myocardial Infarction Trial (clinicaltrials.gov) - Aug 1, 2013 P2b, N=100, Recruiting, Not yet recruiting --> Recruiting | Initiation date: Apr 2017 --> Sep 2017 Initiation date: Apr 2013 --> Jul 2013
|